Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients
Author(s) -
Daniel Podzamczer,
Arkaitz Imaz,
Ignacio Pérez,
Pompeyo Viciana,
Eulalia Valencia,
Jordi Curto,
T. John Martin,
Manuel Castaño,
R. Domínguez,
Núria Espinosa,
Víctor Moreno,
Víctor Asensi,
José Antonio Iribarren,
Bonaventura Clotet,
Luís Force,
P Bachiller,
Hernando Knobel,
J. C. L. Bernaldo de Quirós,
José Ramón Blanco,
Nerea Rozas,
Jorge Vergas,
Antonio Ocampo,
Ángela Camacho,
Juan Flores,
J. L. Gómez-Sirvent
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku157
Subject(s) - darunavir , medicine , abacavir , lamivudine , ritonavir , regimen , viral load , gastroenterology , virology , human immunodeficiency virus (hiv) , hepatitis b virus , antiretroviral therapy , virus
To present clinical experience with a regimen including abacavir/lamivudine + darunavir/ritonavir in a cohort of HIV-1-infected patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom